Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
186.95
-0.63 (-0.34%)
At close: Nov 14, 2025, 4:00 PM EST
187.60
+0.65 (0.35%)
Pre-market: Nov 17, 2025, 8:27 AM EST
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 15 analysts that cover Quest Diagnostics stock have a consensus rating of "Buy" and an average price target of $194.07, which forecasts a 3.81% increase in the stock price over the next year. The lowest target is $172 and the highest is $215.
Price Target: $194.07 (+3.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 7 | 8 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $190 → $200 | Hold | Maintains | $190 → $200 | +6.98% | Oct 27, 2025 |
| Barclays | Barclays | Hold Maintains $190 → $195 | Hold | Maintains | $190 → $195 | +4.31% | Oct 22, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $195 → $205 | Hold | Maintains | $195 → $205 | +9.65% | Oct 22, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $203 → $210 | Buy | Maintains | $203 → $210 | +12.33% | Oct 21, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $200 → $215 | Strong Buy | Maintains | $200 → $215 | +15.00% | Oct 21, 2025 |
Financial Forecast
Revenue This Year
11.09B
from 9.87B
Increased by 12.37%
Revenue Next Year
11.48B
from 11.09B
Increased by 3.51%
EPS This Year
9.90
from 7.69
Increased by 28.78%
EPS Next Year
10.47
from 9.90
Increased by 5.76%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.6B | 12.2B | |||
| Avg | 11.1B | 11.5B | |||
| Low | 10.7B | 11.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.0% | 9.5% | |||
| Avg | 12.4% | 3.5% | |||
| Low | 8.8% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.33 | 11.28 | |||
| Avg | 9.90 | 10.47 | |||
| Low | 9.56 | 9.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 34.4% | 13.9% | |||
| Avg | 28.8% | 5.8% | |||
| Low | 24.4% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.